ECOG-ACRIN NHLBI-MDS: The National Myelodysplastic Syndromes Natural History Study
Objective
Multi-center study enrolling patients suspected or newly diagnosed with myelodysplastic syndromes (MDS), myelodysplastic syndromes/myeloproliferative neoplasms (MDS/MPN) overlap disorder, or idiopathic cytopenia of undetermined significance (ICUS). Participants will be followed long term. Clinical data, blood, and tissue samples will be collected to establish a biorepository to facilitate the study of the natural history of MDS.
https://clinicaltrials.gov/ct2/show/NCT02775383
Location: Essentia Health Cancer Centers
Research Study Categories
Specialties
- Hematology
Contact
Cancer Clinical Trials at 218-786-3308 or 844-681-7944, [email protected]